Professor Robert Leonard is a Professor of Medical Oncology based at Imperial College, London.

Prof Leonard originally trained and qualified at Charing Cross Hospital, where he was awarded the Clinical Gold Medal and six of the final year prizes. He Undertook Post-graduate research Fellowships at Oxford’s Radcliffe Infirmary and Harvard Medical School and later went to to become Professor of Medical Oncology at Swansea Medical School and Director of the South West Wales Cancer Institute. His current roles include Professor of Cancer Studies and Chief of Service for Medical Oncology at Imperial College, London.

Robert is a medical oncologist with a major interest in the management of breast cancer. He is a co-founder and Medical Director for  Maggies’ Cancer Caring Centres UK, and has chaired the professional advisory board. Since 2009 he has been Chair of the Scientific Board for  Breast Cancer Care UK. He set up and Chairs the  International Anglo Celtic Collaborative Oncology Trials Group. He is author/co-author of more than 350 peer reviewed original papers and reviews. He has been a senior advisor to Cancer Research UK and is lead investigator several previous and current UK clinical Trials. He also regularly acts as expert oncology witness for legal cases.

Professor Leonard is multi-lingual speaking English, French and Spanish.

Dr Paula Wells is a Consultant Clinical Oncologist based at Barts NHS Trust.

Dr Wells' oncology training was undertaken at St. Bartholomew’s, UCLH and Mount Vernon Hospitals.  Following her Fellowship, she undertook a postgraduate research degree at Imperial College School of Medicine, Hammersmith Hospital. There she investigated the potential for Positron Emission Tomography (PET) to demonstrate the biological effects of chemotherapy in tissue. She has published a number of papers in this area and was awarded a PhD for her work. Subsequently she completed her post doctoral training at the Royal Marsden Hospital, principally with the Academic Urology Unit.

Dr Paula Wells specialises in the management of patients with genitourinary (bladder and prostate) and thoracic (lung and mesothelioma) malignancies. Furthermore Dr Wells has expertise in the delivery of real time dynamic prostate brachytherapy for patients with early stage, localised prostate cancer.

Dr Wells has recieved numberous awards including :

Rohan Williams Medal CLinical Oncology 1994
British Oncological Association Young Investigator Award 1996
European Society for Therapeutic Radiation Oncology Travel Award 1996
Winner of Royal College of Radiologists national competition for Glaxo Wellcome Fellowship 1996
American Society Clinical Oncology Merit Award 1997
Cancer Research Campaign Clinical Research Fellowship 2000

Dr Paul Ross is a Consultant Medical Oncologist based at Guy’s & St Thomas’ NHS Foundation Trust, London, where he is Clinical Lead for Chemotherapy and he also consults from King’s College Hospital.  He was appointed Consultant in 2004.

Dr Ross graduated from Guy’s hospital, London after training at the Royal Marsden Hospital and complered a PhD at the institute for cancer research. 

He treats patients with colorectal cancer, oesophago-gastric cancer, pancreatic cancer, malignancies of the bile duct and gall bladder (cholangiocarcinoma) and primary liver cancer (hepatocellular cancer). In addition Dr Ross treats patients with neuroendocrine (carcinoid) tumours. He is focused on treating patients with cancer with chemotherapy and biological therapies. He has an interest in the use of locoregional therapies for liver tumours including SIRT.

Dr Ross is a member of the London Cancer New Drugs, which advises on the introduction of new drugs throughout the London area and their prioritisation.. He is Treasurer of the Association of Cancer Physicians of the United Kingdom. He is also a member of the advanced disease subgroup of the NCRI Colorectal Clinical Studies Group. 

He has been awarded the McElwain Prize, Association of Cancer Physicians in 2002 and previously in 2001 he was awarded the ASCO Merit Award, American Society of Clinical Oncology.

Dr Joseph Azzopardi is a Consultant in Pain Medicine and Anaesthesia based at Guy's and St Thomas' Hospital.

Dr Azzopardi graduated from the University of Malta in 1993. He commenced training in Ireland and subsequently undertook higher specialist training in London at The Barts and The London School of Anaesthesia and other associated hospitals. He was a visiting fellow in Regional Anaesthesia in Sweden and in 2002 undertook a two-year fellowship in Pain Medicine in Australia.

Dr Azzopardi is a Fellow of the Royal College of Anaesthetists UK. He was awarded the Fellowship of the Faculty of Pain Medicine of the Australian and New Zealand College of Anaesthetists in 2004. He is a Foundation Fellow of the Faculty of Pain Medicine of the Royal College of Anaesthetists since 2007.

In addition to his expertise in degenerative spine disease, which includes the management of back and neck pain, arm pain and sciatica; he has expertise in Cancer Pain Management and Symptom Control. 

His specialist interests include Interventional Pain Management, Advanced Radiofrequency Ablation Pain Therapies and Neuromodulation (Spinal Cord Stimulation & Neuro-axial Drug Delivery).

Dr Azzopardi also provides Medico-Legal specialist reports and accepts instructions for defendant and claimant personal injury work.  

Dr Azzopardi was appointed as Consultant in Pain Medicine & Anaesthesia in Guy's and St. Thomas' Hospital in 2005. Since taking up his post he has been actively involved with the development of Multidisciplinary Integrated Cancer Pain Services at Guys and St.Thomas' Foundation Trust.

Dr Azzopardi has a keen interest in Medical Education and sits on the London Deanery Pain Training Advisory Group Committee. He is the Educational Supervisor for Advanced Pain Training.

His anaesthetic interests include Difficult Airway Anaesthesia, Regional Anaesthesia and Anaesthesia in the Developing World. He has been the lead anaesthetist on numerous charity missions in Ethiopia with Facing Africa and Project Harar.

In addition to his regular consulting days at the London Bridge Hospital, The Wellington Hospital and Hospital of St John & St Elizabeth, Dr Azzopardi is also available to see urgent patients within 24 hours.

Dr Andrew Gaya is a Consultant Clinical Oncologist based at Guy's and St. Thomas' NHS Foundation Trust.

Dr Gaya originally qualified at St George’s Hospital Medical School (University of London) where he was awarded a distinction and several academic prizes. He trained in Clinical Oncology at Imperial College and St Bartholomew’s Hospital and subsequently undertook a Cancer Research UK MD Fellowship at University College London.

Dr Gaya treats solid tumours using chemotherapy, radiotherapy, and biological therapy – His main focus is on colorectal cancer, cancers of the oesophagus, stomach, pancreas, liver, and lung cancer. Dr Gaya’s main research interest is in the area of functional cancer imaging, where he is looking for ways to assess response to treatment much earlier and techniques for assessing blood flow and oxygen levels within cancers.

He is also heavily involved with the implementation of the latest radiotherapy techniques such as IMRT, IGRT and Tomotherapy, combining targeted or anti-vascular drugs with radiotherapy, and stereotactic body radiosurgery. He is one of the first UK doctors to use the CyberKnife stereotactic body radiosurgery unit. He has published widely in peer-reviewed journals, and is currently lead clinical oncologist for audit and clinical governance at Guy’s and St Thomas’ NHS Foundation Trust.

Dr Greg Wilson is a Consultant Medical Oncologist based at The Christie NHS Foundation Trust in Manchester.

Dr Wilson has interests in breast cancer, colorectal cancer and targeted liver therapies such as SIRT and ChemoSaturation.

He sees private patients at The Christie Clinic in Manchester, The Alexandra Hospital in Cheadle, The London Oncology Clinic and The Harley Street Clinic in London.

He graduated in Medicine from the University of Glasgow in 1988 and after working as a junior doctor in the UK, spent four years in Australia, working firstly in General Medicine and then latterly at advanced trainee level in Medical and Radiation Oncology in Sydney. After returning to the United Kingdom, he completed Specialist Training in Medical Oncology at St James’s University Hospital in Leeds.  He was appointed to the post of Consultant Medical Oncologist at The Christie Hospital, Manchester in 2002.

He is a senior member of the Breast and Colorectal Cancer Groups at The Christie and is closely involved in the Breast and Colorectal Cancer Research Programmes and is principal investigator in national and international trials at The Christie.  

He has a particular interest in the treatment of complex secondary breast and bowel cancer.  He set up, and is Lead Clinician for the Selective Internal Radiation Therapy (SIRT) service for secondary liver tumours and the targeted liver tumour programme at The Christie, the biggest contracted NHS/Private SIRT service in the UK.

He is an educational supervisor within the junior doctor programme and a lecturer in the undergraduate and postgraduate teaching programmes through the University of Manchester and The Christie NHS Trust.

He is active in social media on twitter (@uk_oncologist) and is on the European Society of Medical Oncology Social Media committee and believes in personalized care for individual patients and their needs.  More information can be found on his website drgregwilson.co.uk.